The discovery of significantly reduced serum levels of TRAIL despite higher levels of transcription in patients with COVID‐19, particularly in severe cases, is an unexpected finding that raises essential questions about the role of this molecule in disease pathogenesis. The gene discussed is TNFSF10; the disease is COVID-19.